Product Attributes CAS # : 2107529-15-7 Molecular Formula : C194H295N47O59 Sequence (AA) : HSQGTFTSDYSKYLDEKRAKDFVQWLLNT (modified dual agonist analog) Molecular Weight : ~4332 g/mol PubChem CID : N/A (investigational compound) Half-Life : ~6-8 days Synonyms : IBI362, LY3305677, Mazdutide Type : Synthetic dual GLP-1 / glucagon receptor agonist peptide Research Focus : Metabolism & Weight Regulation, Glycemic Control, Energy Expenditure Scientific References Mazdutide for overweight or obesity in Chinese adults: a randomized, double-blind, placebo-controlled phase 2 trial Human RCT A phase 1 randomized trial to evaluate safety, pharmacokinetics, and pharmacodynamics of IBI362 (LY3305677) in Chinese overweight or obese adults Human RCT Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial Human RCT OXM-based dual GLP-1/glucagon receptor agonists for the treatment of obesity and metabolic disease Observational | Animal | In vitro Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity Human RCT Glucagon-like peptide-1 and glucagon receptor co-agonists: novel therapeutics for obesity and type 2 diabetes Animal | In vitro Anti-obesity drug discovery: advances and challenges Observational | Animal Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
The weight reduction journey frequently brings about a healthier lifestyle, which promotes regular exercise and better eating habits
Neuropharmacology 120 , 2037 (2017)
If they occur, stop the compound and seek medical evaluation immediately
The number of PRP therapy sessions can range from three to six treatments, but this all depends on the specific condition being addressed and the patients response to therapy
